Understanding and treating triple-negative breast cancerTreatment of metastatic melanoma: an overviewAttacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated With Tyrosine Kinase InhibitorsThe Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering ApproachImproving Outcomes in Resectable Gastric Cancer: A Review of Current and Future StrategiesACR Appropriateness Criteria® Borderline and Unresectable Pancreas CancerRecent Advances in Preventing Chemotherapy-Induced Nausea and VomitingMolecular Monitoring of Cell-Free Circulating Tumor DNA in Non-Hodgkin LymphomaUsing Immune Checkpoint Inhibitors in Lung CancerContemporary Issues Surrounding Small Renal Masses: Evaluation, Diagnostic Biopsy, Nephron Sparing, and Novel Treatment ModalitiesAllogeneic Transplantation for Chronic Lymphocytic Leukemia in the Age of Novel Treatment StrategiesNew Agents for the Treatment of Advanced Bladder CancerNeoadjuvant Combined-Modality Therapy for Locally Advanced Rectal Cancer and Its Future DirectionChemoradiation Therapy for Organ Preservation in Localized Male Urethral CarcinomaClinical Management Updates in Mantle Cell LymphomaInjecting Hope--A Review of Breast Cancer VaccinesHow the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?Novel Combination Treatments in Multiple MyelomaThe Role of Intralesional Therapies in MelanomaApplications of Genomic Sequencing in Pediatric CNS TumorsTargeting PARP in Prostate Cancer: Novelty, Pitfalls, and PromiseTreatment of Nonmetastatic Castration-Resistant Prostate CancerAcute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic InsightsIs Personalized Medicine Here?Morphologic, Immunophenotypic, and Molecular Features of Epithelial Ovarian CancerManagement of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical ManagementA Contemporary Review of HPV and Penile CancerFavorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment RecommendationsVaccine Therapy, Oncolytic Viruses, and GliomasThe Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3Langerhans Cell Histiocytosis: Emerging Insights and Clinical ImplicationsNeoadjuvant Therapy for Soft-Tissue SarcomasModern Immunotherapy for the Treatment of Advanced Gastrointestinal CancersSmall- and Large-Cell Neuroendocrine Cervical CancerImmunotherapy: New Strategies for the Treatment of Gynecologic MalignanciesClinical Management of Uveal and Conjunctival MelanomaNeoadjuvant Treatment for Surgically Resectable Metastatic Colorectal CancerPropelling Immunotherapy Combinations Into the ClinicMutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy
P1433
Tumor-specific cell surface expression of the -KDEL containing endoplasmic reticular heat shock protein gp96Finding a place for ceritinib in the landscape of ALK-positive non-small cell lung cancerA phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer
P921
Q24620957-F947B927-E4FA-4E1D-A84F-E3794CB9FD4EQ24642384-43B9B3B4-AB3D-49CC-8867-E3FCC018C3F7Q26739144-875E4810-72FD-4D52-AA0E-BF2E66333C54Q26740051-AC845F1D-EE46-4B53-8BA5-CCB4561146BFQ26740053-BBB944DF-DFA0-4529-ACDA-6BE18599E44AQ26740057-60309D26-24A5-44A6-A495-6FD71014CFAAQ26740368-AB23F470-13EA-40B2-84DF-CEA14F181CE7Q26740371-3EC223E2-0631-4481-A851-873975E84A4BQ26741359-AB932006-DBB2-4DE7-88BA-D50CAD35C19BQ26744278-16E79546-4B27-46B7-AA78-901E93D8E57AQ26745649-31EBA01E-2D3C-426F-9D6C-0CFAB9A1F9D5Q26745843-68940F52-30B3-4ED8-B066-43D922DB1D38Q26745846-D081A60D-5692-44EF-9599-B51E1EDBD619Q26745850-81547646-F620-48E1-82D9-0AEEEE2F9295Q26747637-B661A620-F267-4ACE-853E-E25595942E0CQ26748882-D4D19242-1349-460D-9212-FEB535E2EBFFQ26748884-A52464CA-1684-47D7-94FC-2C082DF5B508Q26748888-081668DD-6E4E-44A9-98CE-275905250C36Q26748890-8DE64510-36AD-4FC0-B089-11C98C9E78B6Q26748892-33CC255C-0A9A-4FAB-9329-B72560BE0786Q26748897-C23A29CB-FE7D-4816-A33A-4C7624A1CF60Q26753031-72E4B042-0150-4D5D-ACCC-D425FEAB4842Q26753035-0D26F414-9EB2-4CA3-988A-DE646D8ED35DQ26753040-F1CEB132-860B-4E5D-BA46-C4923D640D20Q26764862-48B5A7EE-B829-453A-BB7D-334B87CFA7F1Q26764863-607D43A8-6740-4D93-BCAF-7EFCEDCBCA39Q26764972-930060EA-E893-4E80-B4D8-5DB4A2579C04Q26764975-57FB6450-E0F9-4797-AF04-67F35E7173B8Q26764978-7FCE227C-DD11-4C51-86E6-FA788E609FCCQ26764981-83139ABE-CEFD-4103-8710-0EC72BD32E4AQ26765053-3A0C6E7E-C89F-48E0-9B53-F88AC8AD044DQ26765055-674EEE3A-89B9-4C87-A255-9A3086003D24Q26770601-AF175F7C-94D2-4189-A7B4-1B3DCF48A09FQ26770603-2E97B894-534D-4677-B4EB-C1BEBE04AC12Q26770605-D89C55FA-5A6F-456D-80CC-3B726A96D6B0Q26770607-7406743E-AA1B-49D3-8DF9-0CCB97BAD885Q26770610-366205E5-F6C8-4A20-9303-52298CC99509Q26770613-BD88A741-890D-4947-AFCE-C86BB0006A4DQ26774999-DFBF6D4D-597D-46E7-8F6C-93480C601582Q26775170-B12F5FCA-9651-45B9-8DF6-D89215A46333
P1433
description
New York-based journal
@en
begutachtete wissenschaftliche Zeitschrift
@de
periodiek
@nl
name
Oncology
@de
Oncology
@en
Oncology
@nl
type
label
Oncology
@de
Oncology
@en
Oncology
@nl
prefLabel
Oncology
@de
Oncology
@en
Oncology
@nl
P1055
P1156
P1250
P1277
P1476
Oncology
@en